First-Line Treatment of Hairy Cell Leukemia with Cladribine Followed by Rituximab Consolidation Significantly Improves Leukemia-Free Survival

Authors:

Abstract
No abstract available
Funding Information
  • American University of Beirut

This publication has 8 references indexed in Scilit: